Lepa Kalpana of Yogaratnakara: A narrative review
DOI:
https://doi.org/10.70066/jahm.v14i3.2641Keywords:
Bahir-parimarjan, external application, Lepa chikitsa, Lepa Kalpana, skin care, Topical application, Yogaratnakara.Abstract
Background: Acharya Charak has explained three treatment modalities, in which Lepa is one of the widely used models of Bahir-parimarjan (treatment modalities used externally). As other treatises Yogaratnakara is widely popular amongst ayurveda practitioners as a handbook for ayurveda treatments for various diseases. Objectives: To study conceptual foundation of Lepa Kalpana and to analyse data of compiled formulations of Lepa from Yogaratnakara. Material and methods: For conceptual study of Lepa chikitsa comprehensive review of Charak Samhita, Sushrut Samhita, Ashtang Hriday, Sharangdhar Samhita, Bhavaprakash Samhita and Yogaratnakara was done. Formulations of Lepa mentioned in various diseases in Yogaratnakara was compiled, analysed and reported in summarized view. Result: In Yogaratnakara 511 Lepa formulations are described for various diseases and conditions. Benefits of Mukhalepa are emphasized. Contraindications of Lepa chikitsa also explained. Generally, Lepa is a derivative of Kalk Kalpana, but in Yogaratnakara, various formulations of Bhaishajya Kalpana are described for the application of Lepa, like herbal juices, carbonised black coloured ash of herbs, decoction, oils, biomedical fermentations, etc. With Herbal ingredients major mineral, and animal sources are utilized for the formation of Lepa. Lepa chikitsa advised in various conditions of almost 61 diseases. On the basis of study, functions of Lepa are classified into 31 types. Lepa Chikitsa mainly has its local effect, but in some conditions, it shows a systemic effect. Conclusion: Lepa Chikitsa might not be a perfect first line of treatment in all diseases or conditions, but it will provide greater help as a supportive treatment.
References
Srivastav S (editor), Jiwanprada Hindi Commentary, Sharangadhar Samhita, Puvakhanda adhyay 6, verse no. 17, Varanasi; Chaukhamba Orientalia; 2016; 54.
Acharya Siddhinandan Mishra, Abhinav Bhaishajya Kalpana Vidnyan, Chaukhamba Surabharati Prakashan; 1996; 294
Srivastav S., Jiwanprada Hindi Commentry, Sharangadhar Samhita, Uttarakhand 11, verse no. 1, Varanasi; Chaukhamba Orientalia; 2016; 423
Shastri L., Vidyotini commentary, Yogratnakar, Purvardha, Nityapravruttiprakar, Verse no. 88; Chaukhamba Sanskrit Sansthan, 2005; 63
Shastri L., Yogratnakar, Vidyotini commentary, Uttarardha, Samasta Netrarogchikitsa, Bidalakavidhi, verse no. 1, Chaukhamba Sanskrit Sansthan, 2005; 386
Shastri L., Yogratnakar, Vidyotini commentary, Uttarardha, Dantaroga chikitsa verse no. 1, Chaukhamba Sanskrit Sansthan, 2005; 298
Mishra B.S., Bhavmishra, Bhavaprakash edited with Vidyotini commentary, Purva khanda Dwitiya Bhag prakaran 6, verses no. 38-39, Chaukhamba Sanskrit Bhavan, 2020; 1039
Londhe A. Critical review of malahar- Atopical dosage form, World Journal of Pharmaceutical research, vol 10, issue-5, ISSN 2277 7105, Feb 2021:378-388
https://wjpr.s3.ap-south-1.amazonaws.com/article_issue/1619779816.pdf
Srivastav S., Sharangadhar Samhita, Jiwanprada Hindi Commentry, Uttarakhand 11, verse no. 1, Chaukhamba Orientalia, Varanasi. 2016; 423
Tripathi Ravidatta, Astanga Sangraha, Uttarstan Chapter 30, verse no 8, Chaukhamba publication, Varanasi 2001; 554.
Mishra B.S., Bhavmishra, Bhavaprakash edited with Vidyotini commentary, Purva khanda Dwitiya bhag prakaran 6, verse no. 102, Chaukhamba Sanskrit Bhavan, 2020; 1047.
Garde G., Sarth Vagbhat, Sutrasthan 22, verse no. 14, Chaukhamba Surabharati Prakashan, Varanasi, 2018; 90.
Mishra B.S., Bhavmishra, Bhavaprakash edited with Vidyotini commentary, Purva Khanda Dwitiya Bhag prakaran 6, verse no. 101, Chaukhamba Sanskrit Bhavan, 2020; 1047.
Srivastav S., Sharangadhar Samhita, Jiwanprada Hindi Commentry, Uttarakhand 11, verse no. 73 Chaukhamba Orientalia, Varanasi. 2016; 438
Shastri A., Sushruta Samhita, Sutrasthan 18, verse no. 4-5, 12-16, Chaukhamba Sanskrit Sansthan, Varanasi; edition 1989; 74-75
Shastri L., Yogratnakar, Vidyotini commentary, Uttarardha , Shodhanropanvidhi Verse no. 10-12; Chaukhamba Sanskrit Sansthan, 2005; 174
Garde G., Sarth Vagbhat, Sutrasthan 22, verse no. 16-17, Chaukhamba Surabharati Prakashan, Varanasi, 2018; 90
Shastri A., Sushruta Samhita, Sutrasthan18, verse no. 11 Chaukhamba Sanskrit Sansthan, Varanasi, edition 1989;
Shastri L., Yogratnakar, Vidyotini commentary, Purvardha, Shodhanropanvidhi verse 69 Chaukhamba Sanskrit Sansthan, 2005; 61
Garde G., Sarth Vagbhat, Sutrasthan 22, verse no. 17, Chaukhamba Surabharati Prakashan, Varanasi, 2018; 91
Shastri L., Yogratnakar, Vidyotini commentary, Purvardha, Shodhanropanvidhi verse 78, Chaukhamba Sanskrit Sansthan, 2005; 62
Shastri A., Sushruta Samhita, Chikitsasthan 1, verse no. 16, Chaukhamba Sanskrit Sansthan, Varanasi, edition 1989; 5
Shastri A., Sushruta Samhita, Sutrasthan 18, verse no. 6, Chaukhamba Sanskrit Sansthan, Varanasi, edition 1989; 74
Shastri A., Sushruta Samhita, Sutrasthan 18, verse no. 8-11, Chaukhamba Sanskrit Sansthan, Varanasi, edition 1989; 75
Garde G., Sarth Vagbhat, Uttarasthan 25, verse no. 52, Chaukhamba Surabharati Prakashan, Varanasi, 2018; 431.
Garde G., Sarth Vagbhat, Uttarasthana 25, verse no. 38, Chaukhamba Surabharati Prakashan, Varanasi, 2018; 430
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Sushama Raje, Mohan Joshi
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain the copyright of their work and grant the Journal of Ayurveda and Holistic Medicine (JAHM) the right of first publication. All published articles are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) license, which permits non-commercial sharing, use, distribution, and adaptation with proper attribution and the same license terms.
JAHM ensures free, irrevocable, worldwide access to its content. Users may copy, distribute, display, and share published works for non-commercial purposes with appropriate credit to the author(s) and the journal. Limited printed copies for personal, non-commercial use are allowed under the same license.
If a submission is not accepted for publication, the author(s) will be notified.
By submitting, authors confirm that the work is original, that all listed authors have contributed and approved it, and that it does not infringe any third-party rights or duplicate work submitted elsewhere.
